DP-3005

N/A

Report date: 2025/01/26 17:21:21
NME

Base Information

Drug NameDP-3005
Drug Alias NameTCCB (Diakron Pharmaceuticals)T-type calcium channel blocker (Diakron Pharmaceuticals)DP-3005
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated T-type calcium channel blockers
TargetsVoltage-gated T-type calcium channel
Therapy Area/IndicationsHypertensionAngina Pectoris
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDiakron Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesDiakron Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsHypertensionAngina Pectoris
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A